NasdaqGM - Nasdaq Real Time Price • USD
Coherus BioSciences, Inc. (CHRS)
As of 9:40 AM EDT. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
-
-
-
-
-
-
Q4 2023 Coherus BioSciences Inc Earnings Call
Q4 2023 Coherus BioSciences Inc Earnings Call
Thomson Reuters StreetEvents • last month -
-
-
-
-
-
-
-
-
-
-
-
Why Coherus Biosciences Popped Today
Coherus is divesting its non-core ophthalmology franchise.
Motley Fool • 2 months ago -
-
Performance Overview
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | CHRS | S&P 500 |
---|---|---|
YTD | -34.68% | +5.51% |
1-Year | -73.80% | +21.76% |
3-Year | -85.13% | +21.71% |